Vista Investment Partners LLC Buys Shares of 8,014 Corteva, Inc. $CTVA

Vista Investment Partners LLC bought a new position in Corteva, Inc. (NYSE:CTVA) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 8,014 shares of the company’s stock, valued at approximately $537,000.

Several other hedge funds have also recently modified their holdings of the business. Pacer Advisors Inc. lifted its holdings in shares of Corteva by 4,007.1% during the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after purchasing an additional 2,382,715 shares in the last quarter. Amundi increased its holdings in Corteva by 125.3% in the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after buying an additional 1,899,248 shares in the last quarter. Marshall Wace LLP raised its position in Corteva by 1,365.9% in the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock worth $134,882,000 after buying an additional 1,686,309 shares during the last quarter. Squarepoint Ops LLC raised its position in Corteva by 423.6% in the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock worth $117,550,000 after buying an additional 1,406,199 shares during the last quarter. Finally, Man Group plc lifted its stake in Corteva by 16,474.3% during the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company’s stock valued at $87,522,000 after acquiring an additional 1,286,317 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 0.3%

Corteva stock opened at $83.99 on Thursday. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $84.14. The company has a market cap of $56.39 billion, a P/E ratio of 53.16, a P/E/G ratio of 2.86 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The business has a 50-day simple moving average of $77.07 and a two-hundred day simple moving average of $69.88.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the prior year, the company earned $0.32 earnings per share. The firm’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.14% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CTVA. Wolfe Research raised their price target on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. BNP Paribas Exane raised their target price on shares of Corteva from $72.00 to $74.00 in a report on Monday, March 9th. CICC Research lifted their target price on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 11th. Finally, Berenberg Bank boosted their target price on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research note on Thursday, March 26th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $83.19.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.